Lianfeng Lu

1.2k total citations · 1 hit paper
21 papers, 758 citations indexed

About

Lianfeng Lu is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Lianfeng Lu has authored 21 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 8 papers in Virology. Recurrent topics in Lianfeng Lu's work include HIV Research and Treatment (8 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Lianfeng Lu is often cited by papers focused on HIV Research and Treatment (8 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Lianfeng Lu collaborates with scholars based in China and United States. Lianfeng Lu's co-authors include Taisheng Li, Wei Cao, Ling Lin, Xiaojing Song, Xiaosheng Liu, Xiaoxia Li, Yanling Li, Yang Han, Zhifeng Qiu and Xiaodi Li and has published in prestigious journals such as Frontiers in Immunology, BMJ Open and Journal of Translational Medicine.

In The Last Decade

Lianfeng Lu

19 papers receiving 729 citations

Hit Papers

Hypothesis for potential pathogenesis of SARS-CoV-2 infec... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianfeng Lu China 8 554 260 97 85 72 21 758
Marianna Traugott Austria 13 561 1.0× 187 0.7× 54 0.6× 85 1.0× 117 1.6× 37 797
Carlos Salama United States 7 656 1.2× 426 1.6× 94 1.0× 94 1.1× 93 1.3× 12 862
Khai Li Chai Australia 14 725 1.3× 246 0.9× 101 1.0× 64 0.8× 69 1.0× 30 962
Shuibao Xu China 7 534 1.0× 246 0.9× 138 1.4× 123 1.4× 44 0.6× 19 753
Roberto Parrella Italy 14 373 0.7× 198 0.8× 98 1.0× 94 1.1× 111 1.5× 51 826
Hongzhou Lu China 6 265 0.5× 112 0.4× 57 0.6× 62 0.7× 60 0.8× 11 423
Romil Singh United States 15 383 0.7× 219 0.8× 98 1.0× 65 0.8× 63 0.9× 52 725
Yatir Ben‐Shlomo Israel 6 677 1.2× 144 0.6× 42 0.4× 131 1.5× 157 2.2× 9 1.1k
Joon-Sung Joh South Korea 13 528 1.0× 151 0.6× 40 0.4× 261 3.1× 52 0.7× 50 774
Jianyong Zhu China 9 406 0.7× 89 0.3× 49 0.5× 69 0.8× 137 1.9× 15 703

Countries citing papers authored by Lianfeng Lu

Since Specialization
Citations

This map shows the geographic impact of Lianfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianfeng Lu more than expected).

Fields of papers citing papers by Lianfeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianfeng Lu. The network helps show where Lianfeng Lu may publish in the future.

Co-authorship network of co-authors of Lianfeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lianfeng Lu. A scholar is included among the top collaborators of Lianfeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianfeng Lu. Lianfeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Xiaojing, Yanling Li, Mingqiang Li, et al.. (2025). Characterizing pancytopenia in a large Asian cohort of people living with HIV: A 23-year nested case-control study. Journal of Infection and Public Health. 18(8). 102832–102832.
2.
Li, Xiaodi, Ling Chen, Lianfeng Lu, et al.. (2025). Single-cell multi-omics profiling uncovers the immune heterogeneity in HIV-infected immunological non-responders. EBioMedicine. 115. 105667–105667. 4 indexed citations
3.
Chen, Ling, Wei Pan, Lianfeng Lu, et al.. (2025). Prevalence of metabolic syndrome in people living with HIV and its multi-organ damage: a prospective cohort study. BMC Infectious Diseases. 25(1). 351–351. 2 indexed citations
4.
Li, Xiaodi, Ling Xu, Lianfeng Lu, et al.. (2024). Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment. Journal of Translational Medicine. 22(1). 901–901. 1 indexed citations
5.
Lu, Lianfeng, et al.. (2024). Peripheral PD-1+NK cells could predict the 28-day mortality in sepsis patients. Frontiers in Immunology. 15. 1426064–1426064. 3 indexed citations
7.
Lu, Lianfeng, Xiaojing Song, Xiaosheng Liu, et al.. (2024). Clinical and immunological characteristics of HIV/syphilis co-infected patients following long-term antiretroviral treatment. Frontiers in Public Health. 11. 1327896–1327896. 8 indexed citations
8.
Li, Xiaodi, Ling Xu, Lianfeng Lu, et al.. (2023). CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy. Frontiers in Cellular and Infection Microbiology. 13. 1178788–1178788. 3 indexed citations
10.
Liu, Xiaosheng, Xiuxia Li, Jing Xue, et al.. (2023). Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques. International Immunopharmacology. 126. 111173–111173. 1 indexed citations
11.
Liu, Xiaosheng, Yuelun Zhang, Lianfeng Lu, et al.. (2023). Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis. Frontiers in Immunology. 14. 1116738–1116738. 8 indexed citations
12.
Lu, Lianfeng, Yang Yang, Xiaosheng Liu, et al.. (2023). Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy. Frontiers in Immunology. 14. 1254155–1254155. 9 indexed citations
13.
Xu, Ling, Li Zhang, Shuang Kang, et al.. (2023). Immune Responses to HBV Vaccine in People Living with HIV (PLWHs) Who Achieved Successful Treatment: A Prospective Cohort Study. Vaccines. 11(2). 400–400. 2 indexed citations
14.
Liu, Xiaosheng, Ling Lin, Lianfeng Lu, et al.. (2022). Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders. Frontiers in Immunology. 13. 807890–807890. 17 indexed citations
15.
Lu, Lianfeng, et al.. (2022). Reserve sow pose recognition based on improved YOLOv4. 1538–1546. 1 indexed citations
16.
Lu, Lianfeng, Xiaodi Li, Xiaosheng Liu, et al.. (2022). The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients. Aging. 14(23). 9647–9667. 8 indexed citations
17.
Xu, Ling, Xiaodi Li, Lianfeng Lu, et al.. (2022). HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study. Journal of Viral Hepatitis. 29(8). 616–626. 3 indexed citations
18.
Liu, Xiaosheng, Ling Lin, Lianfeng Lu, et al.. (2022). Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders. Phytomedicine. 101. 154103–154103. 16 indexed citations
20.
Song, Xiaojing, et al.. (2021). Immunological changes after COVID-19 vaccination in an HIV-positive patient. International Journal of Infectious Diseases. 117. 230–232. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026